Decision tool
The day and time of your regularly scheduled dose (the one you missed).
Never double up. Taking two doses within the same week dramatically increases the risk of severe nausea, vomiting, dehydration, and in rare cases pancreatitis. Always skip rather than double.
The decision, as a flowchart
→ Take the missed dose now. Resume your regular weekly day.
→ Skip the missed dose. Take your next dose on its regularly scheduled day.
→ Contact your prescriber. You may need to restart at a lower dose to avoid GI rebound.
Based on: Wegovy prescribing information (Section 2.3) and Ozempic prescribing information (Section 2.2).
Why missing matters (and what not to do)
Semaglutide's once-weekly dosing relies on its long half-life (~1 week). That means one missed dose doesn't immediately send your blood levels crashing. A short gap is forgivable; a long one resets some of your acclimation.
What doubling does
Taking a "catch-up" dose within the same week effectively doubles your exposure. Because semaglutide accumulates slowly, this does not catch you up on weight loss — it just spikes GI side effects and dehydration risk. The FDA label is explicit: never double.
What to do if you've stopped for weeks
If you've been off semaglutide for more than two consecutive weeks, don't simply resume at your previous dose. Contact your prescriber. Many clinicians recommend stepping back one titration level (e.g., from 2.4 mg → 1.7 mg for 4 weeks) to prevent the return of acute GI effects.
Reminder: This tool handles routine single missed doses. If you've missed a dose because of a new symptom (e.g., severe abdominal pain, persistent vomiting), call your prescriber before restarting.
References
- Wegovy (semaglutide) FDA prescribing information, Section 2.3 (Missed doses). FDA label PDF · Drugs@FDA
- Ozempic (semaglutide) FDA prescribing information, Section 2.2 (Missed doses). FDA label PDF
- Rybelsus (oral semaglutide) FDA prescribing information, Section 2 (Administration). FDA label PDF